Entresto (sacubitril/valsartan) - Novartis, ROVI Pharmaceuticals Laboratories
Sacubitril/Valsartan Versus Valsartan Alone on Left Atrial Volume Index in Hypertensive Patients (clinicaltrials.gov) - Oct 3, 2026 - P=N/A | N=102 | Not yet recruiting | Sponsor: University of Health Sciences Lahore 
New trial • Cardiovascular • Congestive Heart Failure • Hypertension
http://clinicaltrials.gov/ct2/show/NCT07853625
 
Oct 3, 2026
 
Prev Next